¼¼°èÀÇ ÆÁ À§Ä¡ ±â±â ½ÃÀå : ½ÃÀå ÀλçÀÌÆ®, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2032³â)
Tip Location Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
»óǰÄÚµå : 1776194
¸®¼­Ä¡»ç : DelveInsight Business Research LLP
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,750 £Ü 5,281,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,688 £Ü 6,603,000
PDF (2-3 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,625 £Ü 7,922,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,563,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÆÁ À§Ä¡ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 2¾ï 2,117¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2025³âºÎÅÍ 2032³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 4.39%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 3¾ï 1,101¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÆÁ À§Ä¡ ±â±â¿¡ ´ëÇÑ ¼ö¿ä´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀÎ, ƯÈ÷ ¾Ï, ½ÅºÎÀü, ½ÉÇ÷°üÁúȯ°ú °°Àº ¸¸¼ºÁúȯ °ü¸®¿¡¼­ ¸»ÃÊ »ðÀÔÇü Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(PICC) ¹× Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(CVC)ÀÇ »ç¿ë Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ ½ÃÀåÀº Á¦Ç° Çõ½Å°ú ±â¼ú ¹ßÀüÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖÀ¸¸ç, ÁÖ¿ä Á¦Á¶¾÷üµéÀº ECG ¾È³», ÃÊÀ½ÆÄ ÅëÇÕ, ¹«¼± ¿¬°áÀ» Ư¡À¸·Î Çϴ ÷´Ü ÷´Ü È®ÀÎ ½Ã½ºÅÛ °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ½ÃÀåÀÇ ¸ð¸àÅÒÀÌ Áõ°¡Çϰí Áö¼ÓÀûÀÎ È®ÀåÀ» À§ÇÑ À¯¸®ÇÑ È¯°æÀÌ Á¶¼ºµÇ°í ÀÖÀ¸¸ç, 2025³âºÎÅÍ 2032³â±îÁö ÆÁ À§Ä¡ ±â±â ½ÃÀåÀº °ß°íÇÏ°í ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÆÁ À§Ä¡ ±â±â ½ÃÀå ¿ªÇÐ:

¸¸¼ºÁúȯ °ü¸®¿¡¼­ ¸»ÃÊ »ðÀÔÇü Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(PICC) ¹× Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(CVC)¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÆÁ À§Ä¡ÃßÀû ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤È®ÇÑ Ä«Å×ÅÍ »ðÀÔÀº ȯÀÚÀÇ ¾ÈÀü, È¿°úÀûÀÎ Ä¡·á, ¿À»ðÀÔ, À̵¿, Ç÷ÀüÁõ, °¨¿° µîÀÇ ÇÕº´Áõ °¨¼Ò¸¦ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á ±â°üÀÌ ¾ÈÀü, È¿À²¼º, ¸ð¹ü »ç·Ê Áؼö¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥ ÷´Ü ÆÁ À§Ä¡ÃßÀû ±â±â¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ¾Ï, ½ÅÀå Áúȯ, ÁßÁõ ½Å»ý¾Æ, ½ÉÇ÷°üÁúȯÀÇ ¹ß»ý·ü Áõ°¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Àå±âÀûÀÎ Á¤¸Æ ³»(IV) Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó Ä«Å×ÅÍ »ðÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±¹Á¦¾Ï¿¬±¸¼Ò(International Agency for Research on Cancer)ÀÇ µ¥ÀÌÅÍ(2024³â)¿¡ µû¸£¸é, 2022³â Àü ¼¼°è ¹éÇ÷º´ ½Å±Ô ȯÀÚ ¼ö´Â 48¸¸ 7,000¸í, È£ÁöŲ¸²ÇÁÁ¾ ½Å±Ô ȯÀÚ ¼ö´Â 8¸¸ 2,500¸í, ºñÈ£ÁöŲ¸²ÇÁÁ¾ ½Å±Ô ȯÀÚ ¼ö´Â 55¸¸ 3,000¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å±Ô ȯÀÚ ¼ö´Â 55¸¸ 3,000¸íÀ̾ú½À´Ï´Ù. ÀÌ ¼öÄ¡´Â 2045³â±îÁö °¢°¢ 74¸¸ 6,000¸í, 109¸¸ 9,000¸í, 89¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹éÇ÷º´ ¹× ¸²ÇÁÁ¾ ȯÀÚ´Â È­Çпä¹ý, Ç¥ÀûÄ¡·á, ¸é¿ª¿ä¹ýÀ» ¹Þ±â À§ÇØ CVC ¹× PICC¸¦ ÀÌ¿ëÇÑ Àå±â Á¤¸ÆÁÖÀÔ¿¡ ÀÇÁ¸Çϰí ÀÖÀ¸¸ç, ECG °¡ÀÌµå ½Ã½ºÅÛ, ÀüÀÚ±â À¯µµ ½Ã½ºÅÛ µî ÆÁ À§Ä¡ ±â±âÀÇ »ç¿ëÀº ½Ã¼ú Á¤È®µµ¸¦ ³ôÀ̰í, X-¼± ÀÇÁ¸µµ¸¦ ³·Ã߸ç, ¹æ»ç¼± ³ëÃâÀ» ÃÖ¼ÒÈ­Çϰí, ½Ã¼ú È¿À²À» Çâ»ó½Ãŵ´Ï´Ù. ½Ã¼ú È¿À²À» Çâ»ó½Ãŵ´Ï´Ù. ±× °á°ú, ÀÌ·¯ÇÑ ±â¼úÀÇ Ã¤ÅÃÀº ¾Ï Ä¡·á ÇöÀå¿¡¼­ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ½Å»ý¾Æ ÀÇ·áµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ´Â Áß¿äÇÑ ºÐ¾ßÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é(2023³â) Àü ¼¼°è ¹Ì¼÷¾Æ ¼ö´Â 1,340¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU)¿¡¼­´Â ¹Ì¼÷¾Æ·Î ž ÁßÁõ ½Å»ý¾ÆµéÀÌ ÇÊ¿äÇÑ ¿µ¾ç°ú ¾à¹°À» °ø±ÞÇϱâ À§ÇØ PICC³ª CVC¸¦ ÀÌ¿ëÇÑ Àå±âÀûÀÎ Á¤¸ÆÁÖ»ç Ä¡·á¸¦ ÀÚÁÖ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ½Å»ý¾ÆÀÇ Á¤¸ÆÀº Ãë¾àÇϱ⠶§¹®¿¡ Ç÷ÀüÁõ, °¨¿°, Àå±â ¼Õ»ó°ú °°Àº ÇÕº´ÁõÀ» ÇÇÇϱâ À§Çؼ­´Â Á¤È®ÇÑ Ä«Å×ÅÍ »ðÀÔÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÷´Ü ½Å»ý¾Æ ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½Å»ý¾Æ¿¡°Ô ¾ÈÀüÇϰí Á¤È®ÇÑ Ä«Å×ÅÍ »ðÀÔÀ» º¸ÀåÇϱâ À§ÇØ ÆÁ À§Ä¡ ±â±âÀÇ ÅëÇÕÀÌ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

¸¸¼º ½ÅÀ庴(CKD)µµ ÆÁ À§Ä¡ ±â±â¿¡ Å« ½ÃÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±¹Á¦½ÅÀåÇÐȸ µ¥ÀÌÅÍ(2023³â)¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î ¾à 8¾ï 5,000¸¸ ¸íÀÌ CKD¸¦ ¾Î°í ÀÖ½À´Ï´Ù. ÁøÇà ´Ü°è¿¡ Àִ ȯÀÚ³ª Ç÷¾×Åõ¼®À» ¹Þ´Â ȯÀÚµéÀº ÀæÀº Åõ¼® Ä¡·á, ¾à¹° Åõ¿©, ¼ö¾× ÁÖÀÔÀ» À§ÇØ ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¤¸Æ Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î CKDÀÇ ³ôÀº À¯º´·üÀº Á¤¸Æ Á¢±Ù ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖÀ¸¸ç, Ä«Å×ÅÍ ¹èÄ¡ÀÇ Á¤È®¼º°ú ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ ÆÁ À§Ä¡ °áÁ¤ ±â¼ú¿¡ ´ëÇÑ ¼ö¿äµµ ÇÔ²² Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ BD´Â 2023³â 11¿ù PICC, Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ, Á¤¸ÆÁÖÀÔ°ü, Á¤¸ÆÁÖÀÔ°ü ¹× ±âŸ Ç÷°ü Á¢±Ù ±â±â ¼³Ä¡ ½Ã ÀÓ»óÀÇÀÇ È¿À²À» ³ôÀÏ ¼ö ÀÖµµ·Ï ¼³°èµÈ ÷´Ü ÃÊÀ½ÆÄ ½Ã½ºÅÛÀÎ SiteRite(TM) 9 ÃÊÀ½ÆÄ ½Ã½ºÅÛÀ» Ãâ½ÃÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ÅÍÄ¡½ºÅ©¸°À» žÀçÇÏ¿© È­ÁúÀ» °³¼±ÇÏ°í ¾÷°è ÃÖ°íÀÇ Ä«Å×ÅÍ »ðÀÔ µµ±¸¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛ¿¡´Â ½Ç½Ã°£ ¹Ù´Ã À¯µµ¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â Cue(TM) Needle Tracking System°ú Á¤È®ÇÑ Ä«Å×ÅÍ ÆÁ ¹èÄ¡¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â Sherlock 3CG+(TM) Tip Confirmation System°ú °°Àº ½Ã°¢È­ ±â¼úÀÌ ÅëÇյǾî ÀÖ½À´Ï´Ù.

±×·¯³ª ÆÁ À§Ä¡ ±â±âÀÇ ³ôÀº °¡°Ý, ±â¼úÀû Á¦¾à, ½Ã¼ú»óÀÇ ¹®Á¦ µîÀº ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ÁÖ¿ä Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÆÁ À§Ä¡ ±â±â ½ÃÀå ºÎ¹® ºÐ¼®:

ÆÁ À§Ä¡ ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°(ÆÁ À§Ä¡ ½Ã½ºÅÛ ¹× ¾×¼¼¼­¸®), ±â¼úº°(ECG ±â¹Ý, ÀüÀÚ±â(EM) ³»ºñ°ÔÀÌ¼Ç ECG, ÃÊÀ½ÆÄ À¯µµ ECG), ÃÖÁ¾»ç¿ëÀÚº°(º´¿ø, ¿Ü·¡ ȯÀÚ ¼¾ÅÍ, ±âŸ), Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ±âŸ Áö¿ª)

ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ Á¦Ç° À¯Çüº° ºÎ¹®¿¡¼­ Ĩ À§Ä¡ ½Ã½ºÅÛ Ä«Å×°í¸®´Â 2024³â 88.06%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î Á¾¾ç ¹× °¨¿°¼º ÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ÆÁ À§Ä¡ ±â±â(TLD)¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÎ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ±â±â´Â ±âÁ¸ Ä«Å×ÅÍ »ðÀÔ ¹æ½Ä¿¡ ºñÇØ Å« ÀÌÁ¡À» Á¦°øÇϱ⠶§¹®¿¡ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÆÁ À§Ä¡ ±â±â(TLD)´Â ¸»ÃÊ »ðÀÔÇü Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(PICC)³ª Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ(CVC)ÀÇ Á¤È®ÇÑ À§Ä¡¸¦ À¯µµÇϰí È®ÀÎÇϱâ À§ÇØ ¼³°èµÈ Áß¿äÇÑ ÀÇ·á µµ±¸ÀÔ´Ï´Ù. Ä«Å×ÅÍ ÆÁÀÌ »óºÎ ´ëÁ¤¸Æ(SVC)ÀÇ ÇϺΠ1/3¿¡ ÀÖ´Â ½É¹æÁ߰ݰáÇÕºÎ(CAJ) ºÎ±ÙÀÇ ÃÖÀûÀÇ À§Ä¡¿¡ µµ´ÞÇÏ´ÂÁö È®ÀÎÇÕ´Ï´Ù.

Ä«Å×ÅÍ ¿À¹èÄ¡´Â Ç÷ÀüÁõ, ºÎÁ¤¸Æ, °¨¿°°ú °°Àº ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö Àִµ¥, TLD´Â Ä«Å×ÅÍ ¹èÄ¡ÀÇ Á¤È®µµ¸¦ Å©°Ô Çâ»ó½Ã۰í, È®Àοë X¼±ÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϸç, ½Ã¼ú À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ±× °á°ú, º´¿ø°ú ÀÓ»óÀǵéÀº ±âÁ¸ÀÇ ¾×¼¼¼­¸®¿¡¸¸ ÀÇÁ¸ÇÏÁö ¾Ê°í ±â¼ú ÁÖµµÇü ¼Ö·ç¼ÇÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù.

TLD´Â ÀÏȸ¿ë ¾×¼¼¼­¸®¿¡ ºñÇØ °íºÎ°¡°¡Ä¡ Á¦Ç°À̸ç, ECG ÆÐÄ¡³ª ¸ê±Õ Ä¿¹ö¿Í °°Àº ¾×¼¼¼­¸®´Â Àú°¡ÀÇ ¼Ò¸ðǰÀÎ ¹Ý¸é, TLD´Â ¼öÀͼºÀÌ ³ôÀº ÇÁ¸®¹Ì¾ö °¡°ÝÀÇ ÀåºñÀÔ´Ï´Ù. º´¿øÀº ÇÕº´ÁõÀ» ÁÙÀ̰í È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â ÷´Ü ÀÇ·á±â±â¿¡ ÅõÀÚÇÏ´Â °ÍÀ» ¼±È£ÇÕ´Ï´Ù. ¶ÇÇÑ, Ä«Å×ÅÍ »ðÀÔÀ» È®ÀÎÇϱâ À§ÇØ ±âÁ¸¿¡´Â X¼± °Ë»ç³ª Åõ½Ã °Ë»ç°¡ »ç¿ëµÇ¾î ¿ÔÀ¸³ª, ÀÌ·¯ÇÑ °Ë»ç´Â ¹æ»ç¼± ³ëÃâÀ» Áõ°¡½Ã۰í Ãß°¡ ÃÔ¿µÀ» À§ÇØ ½Ã¼úÀ» Áö¿¬½Ãŵ´Ï´Ù. ÀÌ ¶§¹®¿¡ TLD´Â X¼± ±â¹Ý ¿µ»ó Áø´Ü ½Ã½ºÅÛÀ» ´ëüÇϰí ÀÖÀ¸¸ç, ¾×¼¼¼­¸®º¸´Ù TLD¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¦Ç° ½ÂÀÎ ¹× Ãâ½Ã°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 2¿ù ¼Ò¾Æ ÀÇ·á Çõ½ÅÀ» Àü¹®À¸·Î ÇÏ´Â Navi Medical Technologies´Â ÀÚ»çÀÇ Neonav ECG Tip Location SystemÀÌ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ 510(k) ½ÂÀÎÀ» ¹Þ¾Ò´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

ÀÌ·¯ÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ Ä¨ À§Ä¡ ½Ã½ºÅÛ ½ÃÀåÀº 2025³âºÎÅÍ 2032³â±îÁö ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¸ÅÃâ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ 2024³â ÆÁ À§Ä¡ ±â±â ½ÃÀå¿¡¼­ 48.64%ÀÇ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§´Â ÁÖ·Î Àå±âÀûÀÎ Á¤¸Æ Ä¡·á°¡ ÇÊ¿äÇÑ ¾Ï, ½ÉÇ÷°üÁúȯ, ½ÅÀå Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. º´¿ø°ú ÀçÅÃÀÇ·á ÇöÀå¿¡¼­ PICC¿Í CVCÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 ÷´Ü ÷´Ü È®ÀÎ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» Á¾ÇÕÇϸé, ºÏ¹Ì´Â ¼¼°è ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¾Ï, ƯÈ÷ À¯¹æ¾Ï°ú Æó¾ÏÀÇ ¹ßº´·ü Áõ°¡´Â ÆÁ À§Ä¡ÃßÀû ±â±â¿Í °°Àº ÷´Ü Ç÷°ü Á¢±Ù ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±¹Á¦¾Ï¿¬±¸¼Ò(2025³â)¿¡ µû¸£¸é, 2022³â À¯¹æ¾ÏÀÇ ½Å±Ô ¹ßº´ °Ç¼ö´Â 30¸¸ 6,000°ÇÀ¸·Î ÃßÁ¤µÇ¸ç, ºÏ¹Ì¿¡¼­´Â 2045³â±îÁö 38¸¸ 4,000°Ç¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¶Âù°¡Áö·Î, °°Àº ÀÚ·á¿¡ µû¸£¸é 2022³â ij³ª´ÙÀÇ Æó¾Ï ½Å±Ô ȯÀÚ ¼ö´Â ¾à 31¸¸ 2,000¸íÀ̸ç, ÇâÈÄ 5³â ³» 38¸¸ 5,000¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Lung Cancer CanadaÀÇ µ¥ÀÌÅÍ(2023³â)¿¡ µû¸£¸é, ¸Å³â 32,000¸í ÀÌ»óÀÇ Ä³³ª´ÙÀÎÀÌ Æó¾Ï Áø´ÜÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

ÀÌó·³ ¾Ï ¹ßº´·üÀÌ ³ô°í Áõ°¡ÇÏ´Â Ãß¼¼¿¡ µû¶ó È­Çпä¹ý, ºñ°æ±¸ ¿µ¾ç ¹× ±âŸ Àå±â Ä¡·á¸¦ Áö¿øÇϱâ À§ÇÑ Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ »ðÀÔÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÆÁ À§Ä¡ ±â±â´Â Ä«Å×ÅÍÀÇ Á¤È®ÇÑ ¹èÄ¡, ÇÕº´Áõ °¨¼Ò, ½Ã¼úÀÇ È¿À²¼º Çâ»ó¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, Á¾¾ç »ç·ÊÀÇ ±Þ°ÝÇÑ Áõ°¡´Â ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀ» Á÷Á¢ÀûÀ¸·Î ÃËÁøÇÏ¿© ¼¼°è ÆÁ À§Ä¡ÃßÀû ±â±â ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷µéÀÇ Á¦Ç° °³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁü¿¡ µû¶ó Áö¿ª Àüü ½ÃÀåÀÌ ´õ¿í Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 2¿ù Piccolo MedicalÀº ¸»ÃÊ »ðÀÔÇü Áß½ÉÁ¤¸Æ Ä«Å×ÅÍ Æ÷Áö¼Å´×À» À§ÇÑ SmartPICC(TM) ½Ã½ºÅÛ¿¡ ´ëÇÑ ¹Ì±¹ FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù.

µû¶ó¼­ À§ÀÇ ¸ðµç ¿äÀÎÀ» °í·ÁÇÒ ¶§, ºÏ¹Ì´Â ÇâÈÄ ¸î ³â µ¿¾È ÆÁ À§Ä¡ ±â±â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÆÁ À§Ä¡ ±â±â ½ÃÀå ÁÖ¿ä ±â¾÷

ÆÁ À§Ä¡ ±â±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷À¸·Î´Â BD, Teleflex Incorporated, Vygon (UK) Ltd., Navi Medical Technologies, Seda S.p.A., Piccolo Medical Inc. µîÀÌ ÀÖ½À´Ï´Ù.

ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ ÃÖ±Ù °³¹ß Ȱµ¿:

ÆÁ À§Ä¡ ±â±â ½ÃÀå Á¶»ç º¸°í¼­ÀÇ ÁÖ¿ä ³»¿ë

ÆÁ À§Ä¡ ±â±â ½ÃÀå ÀÚÁÖ ¹¯´Â Áú¹®

1. ÆÁ À§Ä¡ ±â±â

2. ÆÁ À§Ä¡ ±â±â ½ÃÀå ±Ô¸ð

3. ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ ÃËÁø¿äÀÎ

4. ÆÁ À§Ä¡ ±â±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷µé

5. ÆÁ À§Ä¡ ±â±â ½ÃÀå¿¡¼­ °¡Àå ³ôÀº Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¸ñÂ÷

Á¦1Àå ÆÁ À§Ä¡ ±â±â ½ÃÀå º¸°í¼­ ¼Ò°³

Á¦2Àå ÆÁ À§Ä¡ ±â±â ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦3Àå °æÀï ±¸µµ

Á¦4Àå ±ÔÁ¦ ºÐ¼®

Á¦5Àå ÆÁ À§Ä¡ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¿äÀÎ ºÐ¼®

Á¦6Àå Ĩ À§Ä¡ ±â±â ½ÃÀå Porter's Five Forces ºÐ¼®

Á¦7Àå ÆÁ À§Ä¡ ±â±â ½ÃÀå Æò°¡

Á¦8Àå ÆÁ À§Ä¡ ±â±â ½ÃÀå ±â¾÷°ú Á¦Ç° ÇÁ·ÎÆÄÀÏ

Á¦9Àå KOLÀÇ °ßÇØ

Á¦10Àå ÇÁ·ÎÁ§Æ® Á¢±Ù¹ý

Á¦11Àå DelveInsight ¼Ò°³

Á¦12Àå ¸éÃ¥»çÇ×°ú ¹®ÀÇ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Tip Location Devices Market by Product Type (Tip Location System and Accessories), Technology (ECG Based, ECG with Electromagnetic (EM) Navigation, and ECG with Ultrasound-Guided), End-User (Hospitals, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising demand for PICCs & CVCs in chronic disease management and surge in product development drives investment in advanced tip confirmation systems.

The tip location devices market was valued at USD 221.17 million in 2024, growing at a CAGR of 4.39% during the forecast period from 2025 to 2032 to reach USD 311.01 million by 2032. The demand for tip location devices is being driven by several key factors, notably the rising use of peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in the management of chronic diseases such as cancer, renal failure, and cardiovascular conditions. In addition, the market is witnessing a surge in product innovation and technological advancement, with leading manufacturers investing in the development of sophisticated tip confirmation systems featuring ECG guidance, ultrasound integration, and wireless connectivity. Collectively, these factors are fueling strong market momentum and creating a favorable environment for sustained expansion, positioning the tip location devices market for robust and steady growth from 2025 to 2032.

Tip Location Devices Market Dynamics:

The rising demand for peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in chronic disease management is driving the growth of the tip location devices market. Precise catheter placement is essential for patient safety, effective treatment, and reducing complications such as malposition, migration, thrombosis, and infections. As healthcare facilities prioritize safety, efficiency, and compliance with best practices, the demand for advanced tip location devices continues to surge.

One of the primary drivers of market growth is the increasing incidence of cancer, kidney disease, critically ill newborns, and cardiovascular disorders. The rising prevalence of these conditions has led to an increased need for long-term intravenous (IV) therapies, subsequently escalating catheter insertions. According to data from the International Agency for Research on Cancer (2024), global estimates in 2022 indicated 487,000 new cases of leukemia, 82,500 cases of Hodgkin lymphoma, and 553,000 cases of non-Hodgkin lymphoma. These figures are projected to rise to 746,000, 109,000, and 890,000 cases, respectively, by 2045.

Leukemia and lymphoma patients rely on long-term IV access through CVCs and PICCs for chemotherapy, targeted therapies, and immunotherapy. The use of tip location devices, such as ECG-guided and electromagnetic systems, enhances placement accuracy, reduces reliance on X-rays, minimizes radiation exposure, and improves procedural efficiency. As a result, the adoption of these technologies is rapidly increasing in oncology treatment settings.

Furthermore, neonatal care is another key area fueling market expansion. According to the World Health Organization (2023), an estimated 13.4 million babies were born preterm globally. Preterm and critically ill newborns in neonatal intensive care units (NICUs) frequently require long-term IV therapy through PICCs and CVCs for essential nutrients and medications. Given the fragility of neonatal veins, precise catheter placement is critical to avoid complications such as thrombosis, infection, and organ damage. The growing emphasis on advanced neonatal care solutions has consequently driven the integration of tip location devices to ensure safe and accurate catheter placement in newborns.

Chronic kidney disease (CKD) also presents a significant market opportunity for tip location devices. Data from the International Society of Nephrology (2023) indicate that approximately 850 million people worldwide were affected by CKD. Patients in advanced stages or undergoing hemodialysis require reliable venous access for frequent dialysis treatments, medication administration, and IV fluid delivery. The high prevalence of CKD worldwide has heightened the demand for vascular access devices, thereby creating a parallel need for advanced tip location technologies to improve catheter placement accuracy and patient outcomes.

Moreover, in November 2023, BD announced the launch of its advanced ultrasound system designed to enhance clinician efficiency in placing PICCs, central venous catheters, IV lines, and other vascular access devices. The SiteRite(TM) 9 Ultrasound System featured a 15.6-inch touchscreen with enhanced image quality, offering industry-leading catheter placement tools. It incorporated integrated visualization technologies, including the Cue(TM) Needle Tracking System for real-time needle guidance and the Sherlock 3CG+(TM) Tip Confirmation System for accurate catheter tip placement.

However, the high cost of tip location devices, technical limitations & procedural challenges, among others, are some of the key constraints that may limit the growth of the tip location devices market.

Tip Location Devices Market Segment Analysis:

Tip Location Devices Market by Product Type (Tip Location System and Accessories), Technology (ECG Based, ECG with Electromagnetic (EM) Navigation, and ECG with Ultrasound-Guided), End-User (Hospitals, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the tip location devices market, the tip location system category is estimated to account for the largest market share of 88.06% in 2024. This can be attributed to the increasing global prevalence of oncological and infectious diseases, fueling the demand for tip location devices (TLDs). Additionally, these devices offer significant advantages over traditional catheter placement methods, further accelerating their adoption in clinical practice.

Tip location devices (TLDs) are essential medical tools designed to precisely guide and confirm the placement of Peripherally Inserted Central Catheters (PICCs) and Central Venous Catheters (CVCs). They ensure that the catheter tip reaches the optimal position in the lower third of the superior vena cava (SVC) near the cavoatrial junction (CAJ).

Misplaced catheters can lead to serious complications, including thrombosis, arrhythmia, and infections. TLDs significantly improve placement accuracy, minimizing the need for confirmatory X-rays and reducing procedural risks. As a result, hospitals and clinicians are increasingly adopting technology-driven solutions rather than relying solely on traditional accessories.

TLDs are higher-value products compared to single-use accessories. Accessories like ECG patches or sterile covers are low-cost consumables, whereas TLDs are premium-priced devices with higher profit margins. Hospitals prefer investing in advanced medical devices that reduce complications and improve efficiency. Additionally, X-ray and fluoroscopy were traditionally used to confirm catheter placement, but they increase radiation exposure and delay procedures due to additional imaging; thus, TLDs are replacing X-ray-based imaging systems, leading to higher demand for TLDs rather than accessories.

Further, the increasing number of product approvals and launches is also contributing to market growth. For instance, in February 2025, Navi Medical Technologies, a company specializing in pediatric healthcare innovations, announced that its Neonav ECG Tip Location System received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Given these factors, the tip location systems in the tip location devices market are expected to experience substantial revenue growth during the forecast period from 2025 to 2032.

North America is expected to dominate the overall tip location devices market:

North America is projected to hold the largest share of 48.64% in the tip location devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and kidney diseases, which require long-term intravenous therapies. The increasing adoption of PICCs and CVCs in hospitals and homecare settings is further fueling demand for advanced tip confirmation technologies. Collectively, these factors are positioning North America as the leading market in the global tip location devices market.

The increasing incidence of cancer, particularly breast and lung cancer, is significantly contributing to the rising demand for advanced vascular access technologies such as tip location devices. According to the International Agency for Research on Cancer (2025), in 2022, the estimated new cases of breast cancer were 306,000, with projections estimated to reach 384,000 cases by 2045 in North America. Similarly, as per the same source, in 2022, approximately 312,000 new cases of lung cancer in Canada were reported, with projections indicating a rise to 385,000 cases within the next five years. Furthermore, data from Lung Cancer Canada (2023) showed that over 32,000 Canadians were diagnosed with lung cancer each year.

Such high and growing cancer incidence rates are leading to an increased need for central venous catheterizations to support chemotherapy, parenteral nutrition, and other long-term treatments. Tip location devices play a critical role in ensuring accurate catheter placement, reducing complications, and improving procedural efficiency. As a result, the surge in oncology cases is directly fueling the adoption of these devices, thereby driving consistent growth in the global tip location devices market.

Additionally, the increase in product development activities among the key market players is further boosting the overall market across the region. For instance, in February 2021, Piccolo Medical received U.S. FDA clearance of its SmartPICC(TM) System for the positioning of peripherally inserted central catheters.

Therefore, considering all the above-mentioned factors, North America is positioned to have the largest share in the tip location devices market in the upcoming years.

Tip Location Devices Market Key Players:

Some of the key market players operating in the tip location devices market include BD, Teleflex Incorporated, Vygon (UK) Ltd., Navi Medical Technologies, Seda S.p.A., Piccolo Medical Inc., and others.

Recent Developmental Activities in the Tip Location Devices Market:

Key takeaways from the tip location devices market report study

Target audience who can benefit from this tip location devices market report study

Frequently Asked Questions for the Tip Location Devices Market:

1. What are tip location devices?

2. What is the market for tip location devices?

3. What are the drivers for the tip location devices market?

4. Who are the key players operating in the tip location devices market?

5. Which region has the highest share in the tip location devices market?

Table of Contents

1. Tip Location Devices Market Report Introduction

2. Tip Location Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Tip Location Devices Market Key Factors Analysis

6. Tip Location Devices Market Porter's Five Forces Analysis

7. Tip Location Devices Market Assessment

8. Tip Location Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â